0000950123-18-002251.txt : 20180214 0000950123-18-002251.hdr.sgml : 20180214 20180214134100 ACCESSION NUMBER: 0000950123-18-002251 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20171231 FILED AS OF DATE: 20180214 DATE AS OF CHANGE: 20180214 EFFECTIVENESS DATE: 20180214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Pharmstandard International S.A. CENTRAL INDEX KEY: 0001598762 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-17790 FILM NUMBER: 18610520 BUSINESS ADDRESS: STREET 1: 10A, RUE HENRI SCHNADT CITY: LUXEMBOURG STATE: N4 ZIP: L-2530 BUSINESS PHONE: 352 24840131 MAIL ADDRESS: STREET 1: 10A, RUE HENRI SCHNADT CITY: LUXEMBOURG STATE: N4 ZIP: L-2530 13F-HR 1 primary_doc.xml 13F-HR LIVE false true false 0001598762 XXXXXXXX 12-31-2017 12-31-2017 Pharmstandard International S.A.
10a, rue Henri Schnadt Luxembourg N4 L-2530
13F HOLDINGS REPORT 028-17790 N
Eriks Martinovskis Director 352 24840131 /s/ Eriks Martinovskis Luxembourg N4 02-13-2018 1 6 97266 false 1 Joint Stock Co Pharmstandard
INFORMATION TABLE 2 form13fInfoTable.xml INFORMATION TABLE FOR FORM 13F Argos Therapeutics Inc. Common 040221103 39428 13142784 SH DFND 1 0 13142784 0 Argos Therapeutics Inc. Common 040221103 15362 5120604 SH Call DFND 1 0 5120604 0 Proteon Therapeutics Inc. Common 74371L109 3169 1667907 SH DFND 1 0 1667907 0 Protagonist Therapeutics, Inc. Common 74366E102 20431 982270 SH DFND 1 0 982270 0 Jounce Therapeutics, Inc. Common 481116101 8441 662063 SH DFND 1 0 662063 0 Allena Pharmaceuticals Common 018119107 10435 1037267 SH DFND 1 0 1037267 0